← Back to headlines
FDA Grants Breakthrough Status to Johnson & Johnson's Cancer Drug for Advanced Head and Neck Cancer
The FDA has granted Breakthrough Therapy Designation to Johnson & Johnson's cancer drug, JNJ-73841937, for the treatment of advanced head and neck cancer.
21 Feb, 16:31 — 21 Feb, 16:31
ℹOnly 1 source covers this story
